Search Results

Impact of Molnupiravir Treatment on Patient-Reported COVID-19 Symptoms in the Phase 3 MOVe-OUT Trial: A Randomized, Placebo-Controlled Trial.

• Authors : Guan, Yanfen; Puenpatom, Amy; Johnson, Matthew G

Subjects: STATISTICS; DISEASE progression; COVID-19

• Source: Clinical Infectious Diseases; Dec2023, Vol. 77 Issue 11, p1521-1530, 10p

Record details

Concordance between two methods in measuring treatment adherence in patients with type 2 diabetes

• Authors : Lopez-Simarro, Flora; Brotons, Carlos; Moral, Irene

• Source: Patient Preference and Adherence. March 2020, p743, 8 p.

Record details

Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial.

• Authors : Gaziano, J Michael; Brotons, Carlos; Coppolecchia, Rosa

• Source: The Lancet. 2018, Vol. 392, Issue 10152, pages. 1036

Record details

An international multidisciplinary consensus statement on MAFLD and the risk of CVD.

• Authors : Zhou, Xiao-Dong; Targher, Giovanni; Byrne, Christopher D.

• Source: Hepatology International; Aug2023, Vol. 17 Issue 4, p773-791, 19p

Record details

Association between periodontal diseases and cardiovascular diseases, diabetes and respiratory diseases: Consensus report of the Joint Workshop by the European Federation of Periodontology (EFP) and the European arm of the World Organization of Family Doctors (WONCA Europe)

• Authors : Herrera, David; Sanz, Mariano; Shapira, Lior

Subjects: PERIODONTITIS treatment; DIAGNOSIS of diabetes; DIABETES risk factorsEUROPE

• Source: Journal of Clinical Periodontology; Jun2023, Vol. 50 Issue 6, p819-841, 23p, 1 Diagram

Record details

Comentario del CEIPV a las nuevas Guías Europeas de Prevención Cardiovascular 2021.

• Authors : Brotons, Carlos; Camafort, Miguel; Mar Castellanos, María del

• Source: Nefrologia; May/Jun2023, Vol. 43 Issue 3, p360-369, 10p

Record details

Actualización y validación del riesgo cardiovascular de por vida en España: IBERLIFERISK2

• Authors : Brotons, Carlos; Moral-Peláez, Irene; Vicuña, Johanna

• Source: Clínica e Investigación en Arteriosclerosis (ScienceDirect); May-June 2023, Vol. 35 Issue: 3 p115-122, 8p

Record details

Safety and efficacy of a cardiovascular polypill in people at high and very high risk without a previous cardiovascular event: the international VULCANO randomised clinical trial.

• Authors : Mostaza, José M.; Suárez-Fernández, Carmen; Cosín-Sales, Juan

Subjects: LDL cholesterol; CLINICAL trials; CONFIDENCE intervals

• Source: BMC Cardiovascular Disorders; 12/22/2022, Vol. 22 Issue 1, p1-15, 15p

Record details

Effectiveness and Cost-Effectiveness of Case Management in Advanced Heart Failure Patients Attended in Primary Care: A Systematic Review and Meta-Analysis.

• Authors : Checa, Caterina; Canelo-Aybar, Carlos; Suclupe, Stefanie

• Source: International Journal of Environmental Research & Public Health; Nov2022, Vol. 19 Issue 21, p13823, 22p

Record details

Concordance between two methods in measuring treatment adherence in patients with type 2 diabetes

• Authors : Lopez-Simarro, Flora; Brotons, Carlos; Moral, Irene

• Source: Patient Preference and Adherence. Annual 2016, Vol. 10, p743, 8 p.

Record details